Breastfeeding to Prevent NAFLD

HepatologyVolume 74, Issue 6 p. 2939-2941 Editorial Breastfeeding to Prevent NAFLD George Boon-Bee Goh, George Boon-Bee Goh Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore Duke-NUS Medical School, Singapore, SingaporeSearch for more papers by this authorWah Kheong Chan, Wah Kheong Chan Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaSearch for more papers by this authorVincent Wai-Sun Wong, Corresponding Author Vincent Wai-Sun Wong wongv@cuhk.edu.hk orcid.org/0000-0003-2215-9410 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Vincent Wai-Sun Wong, M.B.Ch.B., M.R.C.P. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong 30-32 Ngan Shing Street Shatin, Hong Kong, Hong Kong E-mail: wongv@cuhk.edu.hk Tel.: +852-35051205Search for more papers by this author George Boon-Bee Goh, George Boon-Bee Goh Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore Duke-NUS Medical School, Singapore, SingaporeSearch for more papers by this authorWah Kheong Chan, Wah Kheong Chan Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaSearch for more papers by this authorVincent Wai-Sun Wong, Corresponding Author Vincent Wai-Sun Wong wongv@cuhk.edu.hk orcid.org/0000-0003-2215-9410 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Vincent Wai-Sun Wong, M.B.Ch.B., M.R.C.P. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong 30-32 Ngan Shing Street Shatin, Hong Kong, Hong Kong E-mail: wongv@cuhk.edu.hk Tel.: +852-35051205Search for more papers by this author First published: 09 August 2021 https://doi.org/10.1002/hep.32095 Supported by a direct grant from the Chinese University of Hong Kong (2020.045). Potential conflict of interest: Dr. Goh consults for Boehringer Ingelheim and Gilead. He is on the speakers’ bureau for Echosens and Novo Nordisk. Dr. Wong consults, is on the speakers’ bureau, and received grants from Gilead. He consults and is on the speakers’ bureau for AbbVie, Echosens, and Novo Nordisk. He consults for 3V-BIO, Allergan, Boehringer Ingelheim, Inventiva, Merck, Novartis, Pfizer, ProSciento, Sagimet Biosciences, TARGET PharmaSolutions, and Terns. He is a co-founder of Illuminatio Medical Technology Limited. Dr. Chan consults for Boehringer Ingelheim and Novo Nordisk. He is on the speakers’ bureau for Viatris and Hisky Medical. SEE ARTICLE ON PAGE 2988 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume74, Issue6December 2021Pages 2939-2941 RelatedInformation